Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Grant or award CEO, President acquired 21,552 shares (grant or award)
  2. 4 Grant or award CEO, President acquired 11,811 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 19,379 shares (grant or award)
  6. 4 Grant or award CEO & President acquired 11,627 shares (grant or award)
  7. 4 Grant or award CEO & President acquired 11,194 shares (grant or award)
  8. 4 Grant or award CEO & President acquired 10,204 shares (grant or award)
  9. 4 Grant or award CEO & President acquired 9,146 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy CEO & President bought 15,625 shares at $1.92 ($30,000)
  14. 4 Open-market buy Director bought 10,638 shares at $2.35 ($24,999)
  15. 4 Open-market buy CEO & President bought 11,062 shares at $2.26 ($25,000)
  16. 4 Open-market buy CEO bought 14,535 shares at $1.72 ($25,000)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy CEO & President bought 12,316 shares at $2.03 ($25,001)

Page 6 of 31 · 615 filings